Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Michael R. Hayden, PhD
Age : 66
Public asset : 13,671,215 USD
Linked companies : Aurinia Pharmaceuticals Inc - Xenon Pharmaceuticals Inc
Summary 
Dr. Michael R. Hayden is a Member at American Society of Clinical Investigation, a Scientific Director at Canadian Genetics Diseases Network, a Professor at University of British Columbia and a Program Director at Translational Laboratory in Genetic Medicine.

He is on the Board of Directors at Aurinia Pharmaceuticals, Inc., Xenon Pharmaceuticals, Inc., Royal Society of Canada, American Society of Human Genetics and Lycera Corp. Dr. Hayden was previously employed as a Chief Scientific Officer by Teva Pharmaceutical Industries Ltd. and a Co-Founder by NeuroVir Therapeutic, Inc.

He also served on the board at Michael Smith Foundation for Health Research, Med BioGene, Inc., Aspreva Pharmaceuticals Corp. and Centre for Molecular Medicine & Therapeutic.

He received his undergraduate degree from the University of Cape Town and a doctorate degree from the University of Cape Town.


Current positions of Michael R. Hayden, PhD 
NameTitle Since
Aurinia Pharmaceuticals Inc
(Biotechnology & Medical Research)
Director 2018
Xenon Pharmaceuticals Inc
(Biotechnology & Medical Research)
Independent Director 1996
Canadian Genetics Diseases Network Scientific Director 1990
Lycera Corp. Director -
American Society of Human Genetics Director 1994
Royal Society of Canada Director 1995
University of British Columbia Professor 1983
American Society of Clinical Investigation Member 1992
Translational Laboratory in Genetic Medicine Program Director -


Holdings of Michael R. Hayden, PhD 
NameEquities%Valuation
Teva Pharmaceutical Industries Limited (TEVA)
Pharmaceuticals
475,3390.047%11,288,222 USD
Xenon Pharmaceuticals Inc (XENE)
Biotechnology & Medical Research
259,0211.83%2,382,993 USD
Aurinia Pharmaceuticals Inc (AUP)
Biotechnology & Medical Research
00.0000%0 USD


Michael R. Hayden, PhD: Personal Network 


Most Read News 
07/10JOHN PAULSON : Activist Paulson reduces holding in Britain's Premier Foods
RE
07/12HOCK TAN : Broadcom loses $19 billion in market value after bid to buy CA
RE
06:28aELON MUSK : Tesla shares fall after CEO Musk abuses British caver
RE
07/13JEFF BEZOS : Jeff Bezos plans to charge at least $200,000 for space rides - sources
RE
07/16WARREN BUFFETT : Warren Buffett donates $3.4 billion to Gates' and family charities
RE
07/10MARTIN SORRELL : Tempers flare as Sorrell beats WPP in battle for Dutch agency
RE
07/15ANTTI HERLIN : Thyssen and Kone owners held merger talks on elevator ops
RE
07/16ULRICH LEHNER : Thyssenkrupp in leadership turmoil as chairman quits
RE
07/14RANDALL STEPHENSON : AT&T Stays Course Despite U.S. Appeal -- WSJ
DJ
03:16aWARREN BUFFETT : Top Company News of the Day
DJ
More news


© 2018 People and Ownership :   
Advertisement
Michael R. Hayden, PhD : Connections 
American Society of Hematology
PheroTech International, Inc.
Medrio, Inc.
In Motion Technology, Inc.
Mpm Capital LLC
BC Advantage Funds Ltd.
DiCE Molecules, Inc.
Appili Therapeutics, Inc.
American Academy of Arts & Sciences
Ferghana Partners Group
Massachusetts College of Art & Design
PROOF Centre of Excellence
Massachusetts College of Art Foundation
International Association for the Study of Lung Cancer
The Food & Drug Law Institute
Oric Pharmaceuticals, Inc.



Popular Business Leaders 
Paul Achleitner William Ackman Frank Appel Luc Besson Jeff Bezos Lloyd Blankfein Vincent Bolloré Warren Buffett Patrice Caine Vittorio Colao Tim Cook Serge Dassault Michael Dell Oleg Deripaska Patrick Drahi John Edwards Bill Gates Carlos Ghosn David Henry Heinrich Hiesinger Carl Icahn Brian Krzanich Arnaud Lagardère Daniel Loeb Jack Ma Laurent Mignon Dennis Muilenburg Rupert Murdoch Elon Musk Xavier Niel Frédéric Oudéa Gavin Patterson Georges Plassat Wolfgang Porsche Sumner Redstone Alexandre Ricard Wilbur Ross Howard Schultz Masayoshi Son George Soros Martin Sorrell Rupert Stadler Tidjane Thiam Peter Thiel Viktor Vekselberg John Williamson Martin Winterkorn Steve Wynn Dieter Zetsche Mark Zuckerberg
A-Z Business Leaders